Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer (original) (raw)
Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer
Gerald Verhaegh
2021
View PDFchevron_right
Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer
Gwo-Shu Lee
The Prostate, 2012
View PDFchevron_right
Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
kim chi
International journal of molecular sciences, 2013
View PDFchevron_right
Dual strands of pre-miR-150 (miR-150-5p and miR-150-3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer
Naohiko Seki
International Journal of Oncology, 2017
View PDFchevron_right
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Dian Wang
European Urology, 2015
View PDFchevron_right
A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers
Noor Ahmad
Frontiers in Genetics
View PDFchevron_right
The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer
Myles Brown
The Prostate, 2012
View PDFchevron_right
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
Patricia Bastick
British journal of cancer, 2017
View PDFchevron_right
Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis
Valéria Tavares
International Journal of Molecular Sciences
View PDFchevron_right
Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
Naohiko Seki
Molecular Oncology, 2018
View PDFchevron_right
The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
Margaritis Avgeris
British journal of cancer, 2013
View PDFchevron_right
Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
Katherine Tzou, Ravishankar Ram Mani
Cancers, 2020
View PDFchevron_right
{"__content__"=>"A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting .", "i"=>{"__content__"=>"TMEM97"}}
Inês Graça
Clinical epigenetics, 2018
View PDFchevron_right
Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
Chen-Lin Hsieh
PLOS ONE, 2017
View PDFchevron_right
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis
Hans Lilja
Carcinogenesis, 2015
View PDFchevron_right
Recent updates on the role of microRNAs in prostate cancer
Aamir Ahmad
Journal of Hematology & Oncology, 2012
View PDFchevron_right
THE MIR-15A/MIR-16-1 CLUSTER CONTROLS PROSTATE CANCER PROGRESSION BY TARGETING MULTIPLE ONCOGENIC ACTIVITIES
Giovanni Muto
Eur Urol Suppl, 2008
View PDFchevron_right
MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer
Ewa Ciszkowicz
International Journal of Molecular Sciences
View PDFchevron_right
THE MIR-15A/MIR-16-1 CLUSTER CONTROLS PROSTATE CANCER PROGRESSION CONTROL BY TARGETING OF MULTIPLE ONCOGENIC ACTIVITIES
A. Addario, Giovanni Muto
The Journal of Urology, 2009
View PDFchevron_right
MicroRNA profile analysis of human prostate cancers
Alex Tong
2008
View PDFchevron_right
An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer
Maria Duhagon
Experimental Hematology & Oncology
View PDFchevron_right
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Raffaella Giuffrida
Nature Medicine, 2008
View PDFchevron_right
Treating metastatic prostate cancer with microRNA-145
Andre Bordini
Apoptosis : an international journal on programmed cell death, 2018
View PDFchevron_right
MicroRNA expression profiles in the progression of prostate cancer—from high-grade prostate intraepithelial neoplasia to metastasis
Miguel Srougi
Urologic Oncology: Seminars and Original Investigations, 2013
View PDFchevron_right
MicroRNA-4719 and microRNA-6756-5p Correlate with Castration-Resistant Prostate Cancer Progression through Interleukin-24 Regulation
Dibash Das
Non-Coding RNA
View PDFchevron_right
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Stéphanie Combe
Oncogene, 2019
View PDFchevron_right
1301 the Functional Significance of MICRORNA-145 in Prostate Cancer
Sharanjot Saini
The Journal of Urology, 2010
View PDFchevron_right
In silico Meta-Analysis of Circulatory microRNAs in Prostate Cancer
anshika singh
Journal of Analytical Oncology, 2017
View PDFchevron_right
miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer
Dibash Das
Translational oncology, 2016
View PDFchevron_right
Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer
Irina Groisman
Biology Direct
View PDFchevron_right
The functional significance of microRNA145 in prostate cancer
Saif Majid
British Journal of Cancer, 2010
View PDFchevron_right
The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing
Jonathan Shamash
Frontiers in Cell and Developmental Biology, 2021
View PDFchevron_right
miRNA-mRNA Correlation-Network Modules in Human Prostate Cancer and the Differences between Primary and Metastatic Tumor Subtypes
Wensheng Zhang
PLoS ONE, 2012
View PDFchevron_right